Income favouriteGlaxoSmithKline (LSE: GSK) has finalised its impressively ambitious three-part deal with Swiss giant Novatis, and thusitsshareholders cannow look forward toa 4 billion cash return.
To find out the strategies to adopt if you want tobecome one of the growing number of surprise UK millionaires, read this FREE Motley Fool report:’7 Simple Steps For Seeking Serious Wealth‘ while it remains available!
Do NOT buy these stocks
Theres lots of opportunity out there in todays market but theres also PLENTY of danger.
In anticipation of Champion Shares PROs brief opening to new membership a few short weeks from now, the analyst team behind the Motley Fools most exclusive service has agreed to share 3 stocks they believe YOU would do best to avoid.
PRO research is rarely made available to the general public. To find out the names of these “don’t buy” companies — and to claim your 100% FREE copy of Steer Clear Stocks right away — simply click here.